Luis González Bayón-rekin lankidetzan egindako argitalpenak (7)

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

2011

  1. Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7)

    Annals of Surgical Oncology

2010

  1. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi-institutional study

    Journal of Surgical Oncology, Vol. 102, Núm. 6, pp. 565-570

2007

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement

    Annals of Surgical Oncology, Vol. 14, Núm. 1, pp. 128-133

  2. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals

    Clinical and Translational Oncology, Vol. 9, Núm. 10, pp. 652-662

2006

  1. Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy

    European Journal of Surgical Oncology, Vol. 32, Núm. 6, pp. 628-631